# Ling Yang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ling-yang-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,009 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 28 |
| i10-index | 40 |
| Last Known Institution | Tongji University |
| OpenAlex ID | https://openalex.org/A5029111102 |
| ORCID iD | https://orcid.org/0000-0002-7586-3922 |
| Works | 88 |

## Researcher papers

- [Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial](https://scholariq.org/papers/ramucirumab-versus-placebo-as-second-line-treatment-in-patients-with-advanced/)
- [Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies](https://scholariq.org/papers/genomic-dissection-of-population-substructure-of-han-chinese-and-its-implication/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

## Researcher university

- [Tongji University](https://scholariq.org/institutions/tongji-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.